The WACC of Urogen Pharma Ltd (URGN) is 8.4%.
| Range | Selected | |
| Cost of equity | 7.20% - 10.90% | 9.05% |
| Tax rate | 1.50% - 2.10% | 1.80% |
| Cost of debt | 5.00% - 5.00% | 5.00% |
| WACC | 6.8% - 10.0% | 8.4% |
| Category | Low | High |
| Long-term bond rate | 3.9% | 4.4% |
| Equity market risk premium | 4.6% | 5.6% |
| Adjusted beta | 0.72 | 1.08 |
| Additional risk adjustments | 0.0% | 0.5% |
| Cost of equity | 7.20% | 10.90% |
| Tax rate | 1.50% | 2.10% |
| Debt/Equity ratio | 0.19 | 0.19 |
| Cost of debt | 5.00% | 5.00% |
| After-tax WACC | 6.8% | 10.0% |
| Selected WACC | 8.4% | |